Author of the publication

Phosphoprotein Patterns Predict Trametinib Responsiveness and Optimal Trametinib Sensitisation Strategies in Melanoma

, , , , , , , , , , , , and . Cell Death & Differentiation, 26 (8): 1365-1378 (2019)
DOI: 10.1038/s41418-018-0210-8

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide, , , , , , , , , and 1 other author(s). Journal of Investigative Dermatology, 129 (6): 1500--1515 (June 2009)IgG-single-chain TRAIL fusion proteins for tumour therapy, , , , , , , and . Scientific Reports, 8 (1): 7808 (December 2018)Tyrosine phosphatase inhibition triggers sustained canonical serine-dependent NFκB activation via Src-dependent blockade of PP2A, , , and . Biochemical Pharmacology, 80 (4): 439--447 (2010)Phosphoprotein Patterns Predict Trametinib Responsiveness and Optimal Trametinib Sensitisation Strategies in Melanoma, , , , , , , , , and 3 other author(s). Cell Death & Differentiation, 26 (8): 1365-1378 (2019)Analysing the Role of UVB-Induced Translational Inhibition and PP2Ac Deactivation in NF-κB Signalling Using a Minimal Mathematical Model, , , , , and . PLOS ONE, 7 (7): e40274 (2012)Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28, , , , , , , , , and 9 other author(s). Molecular Cell, 77 (5): 970–984 (2020)Modeling of IL-1 induced NF-κB signaling and analysis of additional UVB influence, , , , , and . Proceedings of the SICE Annual Conference, page 1353--1358. (2007)Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanoma, , , , , , , , , and 3 other author(s). Cell Death & Differentiation, (October 2018)The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells, , , , , , , , , and 8 other author(s). Journal of Investigative Dermatology, 131 (2): 468--479 (2011)IgG-single-chain TRAIL fusion proteins for tumour therapy, , , , , , , and . Scientific Reports, (2018)